AzTrials
AzTrials

Pain, PostoperativeNCT03422783

Correlation Between NOL Index After Stimulus and Post-operative Opioid, Pain, Pre-operative Phenotype

A study testing Standardized tetanic stimulation, Catastrophizing score and Nociceptive threshold in people with Pain, Postoperative and Anesthesia, run by Ciusss de L'Est de l'Île de Montréal at 1 site in Canada.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

This study evaluates the correlation between NoL index response to standardized stimulus under general anesthesia and the post-operative pain, assessed by opioid consumption and numerical pain scores after video-assisted thoracoscopy (VATS). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Pain, Postoperative, Anesthesia, Catastrophizing
What is being tested?
Standardized tetanic stimulation, Catastrophizing score and Nociceptive threshold
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
31 participants
Where
1 siteCanada
Study dates
15 Jan 2018to 7 Mar 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patient (Age 18 or older)
  • ASA status I, II or III
  • elective video assisted thoracoscopy under general anesthesia

Who cannot join

  • history of coronary artery disease
  • serious cardiac arrhythmia (including atrial fibrillation),
  • history of substance abuse,
  • chronic use of psychotropic and/or opioid drugs,
  • use of drugs that act on the autonomic nervous system (including β-blockers),
  • history of psychiatric diseases,
Show all 11Show fewer
  • allergy to any drug used in the study protocol,
  • refusal of the patient
  • unexpected difficult airway requesting excessive, possibly painful airway manipulations
  • unexpected intraoperative complications requiring strong hemodynamic support (transfusions, vasopressors, inotropes)
  • conversion to thoracotomy

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Hopital Maisonneuve Rosemont, CIUSSS de l'Est de l'Ile de Montreal

    Montreal East, Quebec, H1T2M4

Other trials in Canada

About this study

Official title: Correlation Between NoL Index Response to Standardized Stimulus Under General Anesthesia and: Post-operative Opioid Consumption and Pain, Pre-operative Phenotype and Pain Biomarkers

This study evaluates the correlation between NoL index response to standardized stimulus under general anesthesia and the post-operative pain, assessed by opioid consumption and numerical pain scores after video-assisted thoracoscopy (VATS).

Read the detailed description

The NoL index, a nociception monitor using a multiparametric approach, has shown an excellent sensitivity and specificity in detecting noxious stimuli under general anesthesia. This monitor is better than any other parameter in grading nociception under general anesthesia. More recently, it has recently been shown a strong correlation between NoL index response to nociceptive stimulus and the level of opioid analgesia during surgery. No study has evaluated that NoL could predict post-operative pain so far. It has not yet been proven that NoL was correlated with post-operative opioid consumption or with post-operative pain scores.

Some phenotypic factors were previously shown to correlate with post-operative pain and opioid consumption, such as psychological factors and tests, or also assessment of some pre-operative nociceptive thresholds (NT). Pain catastrophizing was proven in several studies to correlate with acute post-operative pain.

So far, no study compared each of these preoperative psychological factors or nociceptif thresholds to the NoL index response to intraoperative standardized pain stimulus in terms of correlation with post-operative opioid requirements and pain scores.

Moreover, there is no study evaluating the pro-inflammatory protein profiles that might likely be correlated to inter-individual differences in NoL response after this standardized nociceptive stimulus under general anesthesia.

This study will assess the level of correlation between NoL index response to standardized stimulus under general anesthesia and the post-operative pain, assessed by opioid consumption and numerical pain scores after video-assisted thoracoscopy (VATS). It also evaluates the correlation between NoL index response to standardized stimulus under general anesthesia and pre-operative phenotype and post-operative pain biomarkers.

Being tested
Standardized tetanic stimulation, Catastrophizing score, Nociceptive threshold, Biomarkers
Keywords
Monitoring, Biomarker, Thoracoscopy
Medical subject headings
Pain, Postoperative, Nociceptive Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standardized tetanic stimulationDevice

    The "intervention" is not a drug, but it is standardized electrical stimulus applied with a muscle relaxation monitor on the forearm of the anesthetized patient. The NoL index is registered in response to this stimulus in an observational manner.

    Device: Device PMD200TM offering intraoperative NoL Index

  • Catastrophizing scoreDiagnostic test

    Pre-operative catastrophizing score is correlated with post-operative pain and opioid consumption

  • Nociceptive thresholdDiagnostic test

    Nociceptive threshold for pressure, heat and electrical stimulation are associated with post-operative pain and will be assessed preoperatively to see if there is correlation between them and the NOL index response to the nociceptive stimulus (see intervention 1)

  • BiomarkersBiological

    Some biomarkers of inflammation and endogenous opioids are associated with post-operative pain. Blood samples will be withdrawn at D0 before surgery starts, D1 (H24) and D2 (H48) after surgery to see if they correlate with NOL changes after the stimulus described in intervention 1 above

Study groups in NCT03422783
Study groupRoleWhat they receive
Included patientsExperimentalThere is only one arm in this study. Intervention will be electrical forearm stimulus under general anesthesia and the response of NOL index following this stimulus and its correlation with postoperative parameters such as pain and opioid consumption in post anesthesia care unit.
Receives: Device: Standardized tetanic stimulation; Diagnostic Test: Catastrophizing score; Diagnostic Test: Nociceptive threshold; Biological: Biomarkers

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Correlation between NoL index and Hydromorphone consumption H24

    Correlation between NoL index absolute values after electrical stimulus under general anesthesia and Total hydromorphone consumption (PACU and PCA) 24h after surgery

    Measured: Day 1 at 24 hours

Secondary outcomes (27)
  1. Pain scores (NRS) in PACU from 0 to 10

    Pain scores from 0 to 10 after surgery, using numerical rating scale in post anesthesiology care unit

    Measured: Day 0 at hour 2

  2. Correlation between NoL index and Pain scores (NRS from 0 to 10) in PACU

    Correlation between NoL index absolute values after electrical stimulus under general anesthesia and Pain scores after surgery, in post anesthesiology care unit

    Measured: Day 0 at hour 2

  3. Pain scores (NRS from 0 to 10) at H24 at rest

    Pain scores (NRS from 0 to 10) at H24 at rest

    Measured: Day 1 at 24 hours

  4. Correlation between NoL index and Pain scores (NRS) from 0 to 10 at H24 at rest

    Correlation between NoL index absolute values after electrical stimulus under general anesthesia and Pain scores (NRS) at H24 at rest

    Measured: Day 1 at 24 hours

  5. Pain scores (NRS) at H24 while coughing from 0 to 10

    Pain scores (NRS) at H24 while coughing from 0 to 10

    Measured: Day 1 at 24 hours

  6. Correlation between NoL index and Pain scores (NRS) from 0 to 10 at H24 while coughing

    Correlation between NoL index absolute values after electrical stimulus under general anesthesia and Pain scores (NRS) at H24 while coughing

    Measured: Day 1 at 24 hours

  7. Pain scores (NRS) at H48 at rest from 0 to 10

    Pain scores (NRS) at H48 at rest from 0 to 10

    Measured: Day 2 at 48 hours

  8. Correlation between NoL index and Pain scores (NRS) from 0 to 10 at H48 at rest

    Correlation between NoL index absolute values after electrical stimulus under general anesthesia and Pain scores (NRS) at H48 at rest

    Measured: Day 2 at 48 hours

  9. Pain scores (NRS) at H48 while coughing from 0 to 10

    Pain scores (NRS) at H48 while coughing from 0 to 10

    Measured: Day 2 at 48 hours

  10. Correlation between NoL index and Pain scores (NRS) from 0 to 10 at H48 while coughing

    Correlation between NoL index absolute values after electrical stimulus under general anesthesia and Pain scores (NRS) at H48 while coughing

    Measured: Day 2 at 48 hours

  11. total hydromorphone consumption (mg) in PACU

    general anesthesia and total hydromorphone consumption (mg) in PACU

    Measured: Day 0 at 2 hours

  12. Correlation between NoL index and total hydromorphone consumption (mg) in PACU

    Correlation between NoL index absolute values after electrical stimulus under general anesthesia and total hydromorphone consumption (mg) in PACU

    Measured: Day 0 at 2 hours

  13. Total hydromorphone consumption (mg) at H48

    Total hydromorphone consumption (mg) at H48

    Measured: Day 2 at 48 hours

  14. Correlation between NoL index and total hydromorphone consumption (mg) at H48

    Correlation between NoL index absolute values after electrical stimulus under general anesthesia and total hydromorphone consumption (mg) at H48

    Measured: Day 2 at 48 hours

  15. Pain catastrophizing scale from 0 to 50 (fully validated and published questionnaire)

    Pain catastrophizing scale from 0 to 50

    Measured: Pre-operative, 2 hours prior to surgery

  16. Correlation between Pain catastrophizing scale from 0 to 50 and Total (hydromorphone consumption at day 1 24 hours)

    Correlation between Pain catastrophizing scale and Total hydromorphone

    Measured: Day 1 at 24 hours

  17. Correlation between Pain catastrophizing scale from 0 to 50 and NoL index

    Correlation between pre-operative Pain catastrophizing scale and NoL index absolute values after electrical stimulus under general anesthesia

    Measured: Day 0

  18. State-Trait anxiety Inventory from 0 to 80 (fully validated and published questionnaire)

    State-Trait anxiety Inventory from 0 to 80

    Measured: Day 0

  19. Correlation between State-Trait anxiety Inventory questionnaire from 0 to 80 and NoL index

    Correlation between pre-operative State-Trait anxiety Inventory and NoL index absolute values after electrical stimulus under general anesthesia

    Measured: Day 0

  20. Correlation between State-Trait anxiety Inventory from 0 to 80 and Total hydromorphone consumption at H24

    Correlation between State-Trait anxiety Inventory and Total hydromorphone consumption at H24

    Measured: Day 1 24 hours

  21. mechanic pain threshold

    mechanic pain threshold using electronic Von Frey

    Measured: Pre-operative, 2 hours prior to surgery

  22. thermal pain threshold

    thermal pain threshold using Qsense device

    Measured: Pre-operative, 2 hours prior to surgery

  23. electrical pain threshold

    electrical pain threshold using Pain Matcher device

    Measured: Pre-operative, 2 hours prior to surgery

  24. Biomarkers level Pre-op

    Biomarkers level Pre-op

    Measured: Pre-operative, H0 right after induction of general anesthesia

  25. Biomarkers level H24

    Biomarkers level H24

    Measured: Day 1 24 hours

  26. Biomarkers level H48

    Biomarkers level H48

    Measured: Day 2 48 hours

  27. Brief Pain inventory (3M) Questionnaire (validated and published questionnaire)

    Brief Pain inventory (3M)

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Feb 2018
  2. Study start15 Jan 2018
  3. Primary completion7 Mar 2024
  4. Study completion7 Mar 2024

Why it stopped: Stopped in march 2024 because lead investigator left Canada

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Model description
Prospective Pilot study
Masking
None (open label)
Enrolment
31 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03422783
Sponsor's protocol ID
2017-1071
Status last verified
Jul 2024
First submitted
11 Jan 2018
Last updated
17 Jul 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Standardized tetanic stimulation, Catastrophizing score and Nociceptive threshold in people with Pain, Postoperative and Anesthesia, run by Ciusss de L'Est de l'Île de Montréal at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 17 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Stopped in march 2024 because lead investigator left Canada). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Correlation between NoL index and Hydromorphone consumption H24 (time frame: Day 1 at 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in